Found: 3
Select item for more details and to access through your institution.
Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production.
- Published in:
- Cellular & Molecular Life Sciences, 2024, v. 81, n. 1, p. 1, doi. 10.1007/s00018-024-05290-4
- By:
- Publication type:
- Article
Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.
- Published in:
- Nature Communications, 2017, v. 8, n. 3, p. 14677, doi. 10.1038/ncomms14677
- By:
- Publication type:
- Article
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-02958-4
- By:
- Publication type:
- Article